Wednesday, September 17th, 2025 - Main Conference Day One - ET (Eastern Time, GMT-05:00)
Join us for an invigorating start to your day with our special wellness combo event!
Fun Run
Lace up your running shoes and hit the trail with colleagues for our energizing Fun Run. Whether you're a seasoned runner or prefer to walk, this inclusive event welcomes participants of all fitness levels. Enjoy the camaraderie, fresh air, and endorphin boost as we move together through scenic surroundings.
Morning Yoga Session
Happening simultaneously, our rejuvenating yoga session offers a peaceful alternative. Our experienced instructor will guide you through gentle poses designed to increase flexibility, reduce stress, and center your mind for the day ahead.
How To Sign Up: Please ask at registration onsite
What to Bring: Comfortable athletic wear, water bottle, sunscreen
- Christopher Bravery, Ph.D. - Consulting Regulatory Scientist, Advbiols
- Kat Kozyrytska - Founder, Cell Therapy Manufacturability Program
- Shashi Murthy - CTO and Co-Founder, Nanite Inc.
- Pauline Schmit - Senior Scientist, nChroma Bio
- Mahesh Bule - Associate Director, Kite Pharma a Gilead Company
- Amy Shaw - Head of Process and Product Development, Takeda, USA
- Mark Farmery - Chief Development Officer, Anocca AB
- Francesca Vitelli, PhD - VP Global head of Process and Analytical Development and Innovation (PADI), Minaris
- Spencer Hoover - Principal Consultant, SH Consulting LLC
- Therese Choquette - Head of Analytical and Translational Sciences, Tigen Pharma
- Thomas Perroud - Global Head of R&D – Personalized Medicine, Lonza
- Catherine Simpson - Conference Director - Cell and Gene Therapy Portfolio, Informa Connect LifeSciences
- Ying Cai - MSAT Executive Director, Ultragenyx Pharmaceutical
- Nripen Singh - Head of Process Development, TRD CGT, Novartis
- Vaishali Shukla - Vice President, CGT & API Global Expansion, Eli Lilly and Company
- James Warren - Senior VP, Global CMC Development, Ultragenyx Pharmaceutical Inc.
- Jordan Ball - Sr. Manager, Technology Transfer, Regeneron
- Kristy Wood - SVP, Technical Operations, Intellia Therapeutics
- Devyn Smith - CEO, Arbor Biotechnologies
- Shawn (Xueyuan) Wang - Director, Process Development, Kite Pharma
- Wonjong Si - Director of Cell Therapy Process Development, Bayer
- Huize Yan - Senior Scientist, Cell Culture Development, Genentech
- Hunter Reese - Scientist II, AskBio
- Kevin Vera - Scientist II, Process Development, Pharma Services Group, Thermo Fisher Scientific
- Junyan Zhang - Sr Manager, Downstream Process Development, Pharma Services Group, Thermo Fisher Scientific
- Mark Farmery - Chief Development Officer, Anocca AB
- Weiyi Li - Senior Manager, LNP Formulation, Prime Medicine
- Shashi Prajapati - Director, Cell & Gene Therapies Analytical Development, Vertex Pharmaceuticals
- Lena Yang - Senior Scientist, Cell Therapy Analytical Development, Takeda
- Therese Choquette - Head of Analytical and Translational Sciences, Tigen Pharma
- David Dobnik - Research Councillor, National Institute of Biology
- Dana Schreffler - Sr. Manager QC Viral Safety, Regeneron
- Shankar Swaminathan, PhD - Team Lead, Drug Product Development, CMC-Tech Ops, Astellas Institute for Regenerative Medicine
- D.J. Harkins - Director, External Manufacturing and Supply, Takeda
- Maura Hobson - Executive Director, External Manufacturing, Sana Biotechnology
- Matthew Provencal - Executive Director Gene Therapy BDS Manufacturing, Sarepta
- Khandan Baradaran - Consulting Leader & Strategic Advisor, PLG North America/Halloran
- Mariska ter Haak - Senior Director Analytical Development, IN8bio
- Dong Xu, Ph.D. - Associate Director, TScan Therapeutics
- Parag Kumthekar - Gene Therapy Downstream Process Development Lead, UCB Pharma